Geoffrey Shapiro
Medical Oncology · Boston, MANPI 1255309316
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Bayer at 26.0% of the total.
Across 30 payments — averaging $1011.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$8K
- EMD Serono Research & Development Institute, Inc.$7K
- Pfizer$6K
- Boehringer Ingelheim International GmbH$3K
- E.r. Squibb & Sons, L.L.C.$3K
- Seagen Inc.$2K
- plus $2K from 5 others
Across 791 payments — averaging $20,442 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$9.5M
- Amgen$1.9M
- Merck Healthcare Kgaa$800K
- Novartis$564K
- Eli Lilly$494K
- Bayer$490K
- plus $2.5M from 22 others
What the payments were for
- Consulting fees$17,58558%
- Speaking & faculty fees$9,19530%
- Travel & lodging$3,12910%
- Food & beverage$3851%
- Education$480%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 6 | $7,875 |
| EMD Serono Research & Development Institute, Inc. | 1 | $6,750 |
| Pfizer(2 entities) | 6 | $5,931 |
| Boehringer Ingelheim International GmbH | 3 | $3,075 |
| E.r. Squibb & Sons, L.L.C. | 1 | $2,608 |
| Seagen Inc. | 3 | $1,901 |
| Blueprint Medicines Corporation | 1 | $1,680 |
| Eli Lilly | 6 | $449 |
| Clovis Oncology, Inc. | 1 | $36 |
| Amgen | 1 | $25 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$30,342 in reported general payments places this provider in the 70th percentile of 308 medical oncology providers in Massachusetts.
Other medical oncology in Boston
- George DemetriBoston$1.6M
- Keith FlahertyBoston$932K
- Alicia MorgansBoston$690K
- Pasi Antero JanneBoston$458K
- Robert HaddadBoston$451K
- Irene GhobrialBoston$431K
- Joaquin Bellmunt MolinsBoston$415K
- Jeremy AbramsonBoston$334K
- Justin GainorBoston$324K
- Narjust FlorezBoston$324K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.